Strandberg Julia Insider Trades

Insider Trading History

Track insider trading activity for Strandberg Julia. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pear Therapeutics
Pear Therapeutics PEAR
Chief Commercial Officer
Holding Value $41.2k 1,409,523 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.48M 1,409,523 shares
$1.05
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Commercial Officer
Holding Value $8.32k 1,409,523 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 1,409,523 shares
$0.11
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Commercial Officer
Holding Value $835 28,612 shares
Last Trade
Jan 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.3k 12,688 shares
$1.13
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Commercial Officer
Holding Value $169 28,612 shares
Last Trade
Jan 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.52k 12,688 shares
$0.12
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Commercial Officer
Holding Value $1.96k 67,000 shares
Last Trade
Jan 14, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.6k 33,000 shares
$1.23
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Commercial Officer
Holding Value $244 41,300 shares
Last Trade
Jan 14, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.96k 33,000 shares
$0.12
$0.01
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Commercial Officer
Holding Value $395 67,000 shares
Last Trade
Jan 14, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.96k 33,000 shares
$0.12
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Commercial Officer
Holding Value $1.21k 41,300 shares
Last Trade
Jan 14, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.6k 33,000 shares
$1.23
$0.03
Pear Therapeutics
Pear Therapeutics PEAR
Chief Commercial Officer
Holding Value $2.92k 100,000 shares
Last Trade
Feb 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$726k 178,780 shares
$4.06
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Commercial Officer
Holding Value $590 100,000 shares
Last Trade
Feb 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.9k 78,780 shares
$0.62
$0.01
Thimble Point Acquisition
Thimble Point Acquisition THMA
Chief Commercial Officer
Holding Value $1.03M 110,431 shares
Last Trade
Dec 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.26M 780,377 shares
$9.30
$9.30
Thimble Point Acquisition - Units (1 Ord Class A & 1/3 War)
Thimble Point Acquisition - Units (1 Ord Class A & 1/3 War) THMAU
Chief Commercial Officer
Holding Value $1.09M 110,431 shares
Last Trade
Dec 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.73M 780,377 shares
$9.90
$9.90
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Commercial Officer
Holding Value $3.69k 625,775 shares
Last Trade
Dec 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$874k 780,377 shares
$1.12
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Commercial Officer
Holding Value $18.3k 625,775 shares
Last Trade
Dec 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.82M 625,775 shares
$9.30
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up